Your browser doesn't support javascript.
loading
Use of trastuzumab and pertuzumab with FOLFOXIRI as neoadjuvant therapy for HER2-positive resectable metastatic colorectal cancer: The first case report.
Pang, Hua-Yang; Yan, Meng-Yua; Chen, Xiu-Feng; Sun, Hao.
Afiliación
  • Pang HY; Department of Gastrointestinal Cancer Center, Chongqing University Cancer Hospital, Chongqing, 400030, China; Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, 400030, China.
  • Yan MY; Department of Gastrointestinal Cancer Center, Chongqing University Cancer Hospital, Chongqing, 400030, China.
  • Chen XF; Department of Gastrointestinal Cancer Center, Chongqing University Cancer Hospital, Chongqing, 400030, China.
  • Sun H; Department of Gastrointestinal Cancer Center, Chongqing University Cancer Hospital, Chongqing, 400030, China. Electronic address: sunhao_med@cqu.edu.cn.
Asian J Surg ; 2024 Jul 24.
Article en En | MEDLINE | ID: mdl-39048442
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Asian J Surg Año: 2024 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Asian J Surg Año: 2024 Tipo del documento: Article País de afiliación: China